Substituted Pyrano [2,3-b] Pyridinamine compounds as beta-secretase modulators and methods of use
申请人:Graceffa Russell
公开号:US20100120774A1
公开(公告)日:2010-05-13
The present invention comprises a new class of compounds useful for the modulation of Beta-secretase enzyme activity and for the treatment of Beta-secretase mediated diseases, including Alzheimer's disease (AD) and related conditions. In one embodiment, the compounds have a general Formula I
wherein R
1
, R
2
, R
3
, R
4
, R
5
, A
1
, A
2
, A
3
, A
4
, X and Z are defined herein. The invention also includes use of these compounds in pharmaceutical compositions for treatment, prophylactic or therapeutic, of disorders and conditions related to the activity of beta-secretase protein. Such disorders include, for example, Alzheimer's Disease (AD), cognitive deficits and impairment, schizophrenia and other similar central nervous system conditions. The invention also comprises further embodiments of Formula II, intermediates and processes useful for the preparation of compounds of Formulas I and II.
本发明包括一类新化合物,用于调节Beta-分泌酶酶活性,治疗由Beta-分泌酶介导的疾病,包括阿尔茨海默病(AD)及相关疾病。在一个实施例中,这些化合物具有一般的化学式I,其中R1、R2、R3、R4、R5、A1、A2、A3、A4、X和Z在此处被定义。该发明还包括将这些化合物用于治疗与beta-分泌酶蛋白活性相关的疾病和情况的药物组合物。这些疾病包括阿尔茨海默病(AD)、认知缺陷和损伤、精神分裂症和其他类似的中枢神经系统疾病。该发明还包括化学式II的进一步实施例,以及有用于制备化学式I和II化合物的中间体和工艺。